1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018

Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018, mainly studies the market, competition pattern and segmentations of human vaccine industry in China and analyzes the industry chain, import & export and key enterprises of human vaccine in China. This report analyzes the business performances of 7 key enterprises, including Beijing Tiantan Biological Products Co., Ltd, ChongQing ZhiFei Biological Products Co., Ltd, Walvax Biotechnology Co., Ltd, Liaoning Chengda Co., Ltd (LCD) etc.

As one of powerful vaccine manufacturing countries in world, China has 42 vaccine manufacturers with approval license. In 2013, the total of lot release quantity of vaccines was about 755 million doses, increasing by 0.53% over the 751 million doses in 2012. Vaccine manufacturers mainly consist of state-owned enterprises, private enterprises and foreign-funded enterprises in China. Seeing from the lot release quantity of vaccine in 2013, the state-owned enterprises still take the leading position in vaccine market, with market shares of 62%, followed by private enterprises and foreign-funded enterprises successively, with market shares of 33.77% and 4.23% respectively.

Most of market of type'vaccines is still dominated by state-owned enterprises, including 6 largest institutes of China National Biotec-Group Company Limited and Changchun Keygen Biological Products Co., Ltd. Private enterprises take half of market shares of type'vaccines, the representative enterprises include: ChongQing ZhiFei Biological Products Co., Ltd, and Walvax Biotechnology Co., Ltd etc. While the international enterprises have definite advantages in respects of high-end vaccines and multivalent vaccines, taking pneumococcal vaccines for instance, only one conjugate vaccine is available, say: Pneumococcal 7-Valent Conjugate Vaccine produced by Pfizer. Although, at present, several enterprises are conducting studies on pneumococcal conjugate vaccines, it is still long to launch on the market, with huge uncertainties.

In 2014-2018, the average growth rate of vaccine in China will maintain at 16%-18%. The main driving factors include: implement of national vaccine immunization plan, increasing receptivity of vaccine by people, rising trend of initiative vaccination and increase of type ?vaccines application etc. It can be expected that the market scale of vaccine will hit CNY 40.5 billion in 2018.

Please note: The report is Chinese version. It will provide the English version in two business days.

Table Of Contents

Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018
1. Overview of Human Vaccine Industry
1.1 Definition and Characteristics
1.1.1 Industry Definition
1.1.2 Product Classification
1.2 Industry Chain
1.2.1 Upstream Market
1.2.2 Downstream Market

2. Development Environment of Human Vaccine in China
2.1 Policy Environment
2.2 Technical Environment
2.2.1 RandD of Vaccines Technology in China
2.2.2 Hot Technologies Analysis
2.2.3 Active Degree of Industry Technology

3. Development of Human Vaccine Industry
3.1 Development Status Quo of Human Vaccine
3.1.1 Overview of Market
3.1.2 Supply in 2013
3.2 Demand of Human Vaccine
3.2.1 Demand in 2013
3.2.2 Demand Forecast, 2014-2018
3.3 Competition Pattern

4. Import and Export of Human Vaccine Industry in China
4.1 Import
4.1.1 Import Data
4.1.2 Import Sources, Jan.-Sept 2014
4.2 Export
4.2.1 Export Data
4.2.2 Export Destinations, Jan.-Sept 2014

5. Segmented Industries of Human Vaccine
5.1 Epidemic Meningitis Vaccine
5.1.1 Industry Status Quo
5.1.2 Segmentations
5.2 Hepatitis B Vaccine
5.2.1 Market Status Quo
5.2.2 Supply
5.2.3 Demand
5.3 Hepatitis A Vaccine
5.3.1 Supply
5.3.2 Demand
5.4 Encephalitis B Vaccine
5.4.1 Supply
5.4.2 Demand
5.5 DPT Vaccine
5.5.1 Supply
5.5.2 Demand
5.6 Influenza Vaccine
5.6.1 Supply
5.6.2 Demand
5.7 Rabies Vaccine
5.7.1 Overview of Market
5.7.2 Supply
5.7.3 Demand
5.8 Pneumococcal Vaccine
5.8.1 Supply
5.8.2 Demand

6. Key Human Vaccine Enterprises in China
6.1 Beijing Tiantan Biological Products Co., Ltd
6.1.1 Company Profile
6.1.2 Business Performance
6.1.3 Vaccine Business
6.2 Hualan Biological Engineering Inc.
6.2.1 Company Profile
6.2.2 Business Performance
6.2.3 Vaccine Business
6.3 Liaoning Chengda Co., Ltd (LCD)
6.3.1 Company Profile
6.3.2 Business Performance
6.3.3 Vaccine Business
6.4 Walvax Biotechnology Co., Ltd
6.4.1 Company Profile
6.4.2 Business Performance
6.4.3 Vaccine Business
6.5 ChongQing ZhiFei Biological Products Co., Ltd
6.5.1 Company Profile
6.5.2 Business Performance
6.5.3 Vaccine Business
6.6 Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd
6.6.1 Company Profile
6.6.2 Vaccine Business
6.7 Changchun BCHT Biotechnology Co., Ltd
6.7.1 Company Profile
6.7.2 Vaccine Business

7. Investment Analysis on Human Vaccine
7.1 Investment Opportunities
7.1.1 Policy Support
7.1.2 Vast Consumption Market
7.2 Investment Risks
7.2.1 Market Competition
7.2.2 Quality Accidents
7.2.3 Product RandD
7.2.4 Core Technician Drain
7.3 Entry Barrier
7.3.1 Administrative Barrier
7.3.2 Capital Barrier
7.3.3 Technical Renovation Barrier
7.4 Development Trend of Human Vaccine Industry
7.4.1 International Blockbuster Products Will be Innovation Goal of Chinese Enterprises
7.4.2 Chinese-foreign Joint Venture Will Become Important Enterprise Development Mode
7.4.3 Children Conjugate Vaccine Will Become Trend

Companies Mentioned

Beijing Tiantan Biological Products Co., Ltd
Hualan Biological Engineering Inc.
Liaoning Chengda Co., Ltd (LCD)
Walvax Biotechnology Co., Ltd
ChongQing ZhiFei Biological Products Co., Ltd
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd
Changchun BCHT Biotechnology Co., Ltd

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Human Vaccines Market: Scope and Methodology This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human ...

Clostridium Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Clostridium Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Clostridium Vaccine (Animal Health) Market: Scope of the Report This report on the clostridium vaccine (animal health) market studies the current as well as future prospects of the market globally. ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.